Emily Faherty, PA
Physician Assistant · Feasterville Trevose, PANPI 1558827519
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 68.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $426 and has fallen 55.9% since, to $188 in 2024.
Across 78 payments — averaging $13.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$736
- Merck$49
- Novo Nordisk$45
- Amgen$38
- Pfizer$32
- Althera Pharmaceuticals LLC$30
- plus $139 from 8 others
What the payments were for
- Food & beverage$1,067100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $736 |
| Merck | 3 | $49 |
| Novo Nordisk | 3 | $45 |
| Amgen | 2 | $38 |
| Pfizer | 2 | $32 |
| Althera Pharmaceuticals LLC | 2 | $30 |
| Amarin Pharma, Inc. | 2 | $28 |
| GSK | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Phadia US Inc. | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| AstraZeneca | 1 | $12 |
How this compares
$1,067 in reported general payments places this provider in the 75th percentile of 6,643 physician assistant providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $359 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $153 |
| Doxycycline Hyclate | 23 | $127 |
| Methylprednisolone | 26 | $105 |
| Cephalexin | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Feasterville Trevose
- Erin CrownState College$1.2M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Jeffrey CameronWashington$89K
- Dorissa BrivchikPittsburgh$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.